BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17266159)

  • 1. Steroid conjugates of dichloro(6-aminomethylnicotinate)platinum(II): effects on DNA, sex hormone binding globulin, the estrogen receptor, and various breast cancer cell lines.
    Schobert R; Bernhardt G; Biersack B; Bollwein S; Fallahi M; Grotemeier A; Hammond GL
    ChemMedChem; 2007 Mar; 2(3):333-42. PubMed ID: 17266159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of estrogenic and cytotoxic properties of an estrogen receptor-binding platinum complex in human breast cancer cell lines.
    Otto AM; Faderl M; Schönenberger H
    Cancer Res; 1991 Jun; 51(12):3217-23. PubMed ID: 2039997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 17beta-estradiol-linked platinum(II) complexes and their cytocidal activity on estrogen-dependent and -independent breast tumor cells.
    Perron V; Rabouin D; Asselin E; Parent S; C-Gaudreault R; Bérubé G
    Bioorg Chem; 2005 Feb; 33(1):1-15. PubMed ID: 15668178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (Arene)Cl₂Ru(II) complexes with N-coordinated estrogen and androgen isonicotinates: interaction with sex hormone binding globulin and anticancer activity.
    Schobert R; Seibt S; Effenberger-Neidnicht K; Underhill C; Biersack B; Hammond GL
    Steroids; 2011 Mar; 76(4):393-9. PubMed ID: 21184767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platinum complexes with a selective action on estrogen receptor-positive mammary tumors.
    von Angerer E; Birnböck H; Knebel N
    Anticancer Drug Des; 1989 Jun; 4(1):21-35. PubMed ID: 2757751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular targets of the anti-breast cancer agent Z-1,1-dichloro-2,3-diphenylcyclopropane: type II estrogen binding sites and tubulin.
    ter Haar E; Hamel E; Balachandran R; Day BW
    Anticancer Res; 1997; 17(3C):1861-9. PubMed ID: 9216636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor-binding affinity and cytotoxic activity of three new estrogen-nitrosourea conjugates in human breast cancer cell lines in vitro.
    Lam HY; Ng PK; Goldenberg GJ; Wong CM
    Cancer Treat Rep; 1987 Oct; 71(10):901-6. PubMed ID: 3652053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved synthesis of unique estradiol-linked platinum(II) complexes showing potent cytocidal activity and affinity for the estrogen receptor alpha and beta.
    Descôteaux C; Leblanc V; Bélanger G; Parent S; Asselin E; Bérubé G
    Steroids; 2008 Oct; 73(11):1077-89. PubMed ID: 18572212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear estrogen receptor targeted photodynamic therapy: selective uptake and killing of MCF-7 breast cancer cells by a C17alpha-alkynylestradiol-porphyrin conjugate.
    Swamy N; Purohit A; Fernandez-Gacio A; Jones GB; Ray R
    J Cell Biochem; 2006 Oct; 99(3):966-77. PubMed ID: 16741968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex hormone-binding globulin (SHBG) and estradiol cross-talk in breast cancer cells.
    Fortunati N; Catalano MG
    Horm Metab Res; 2006 Apr; 38(4):236-40. PubMed ID: 16700004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular sex hormone-binding globulin (SHBG) in normal and neoplastic breast tissue--an additional marker for hormone dependency?
    Meyer S; Brumm C; Stegner HE; Sinnecker GH
    Exp Clin Endocrinol; 1994; 102(4):334-40. PubMed ID: 7529185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invesgations [correction investigations] on the influence of halide substituents on the estrogen receptor interaction of 2, 4, 5-tris(4-hydroxyphenyl)imidazoles.
    Gust R; Busch S; Keilitz R; Schmidt K; Von Rauch M
    Arch Pharm (Weinheim); 2003 Oct; 336(10):456-65. PubMed ID: 14582122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of interaction of trichloro{eta2-cis-N,N-dimethyl-1-[6-(N',N'-dimethyl-ammoniummethyl)-cyclohex-3-ene-1-yl]-methylammonium}platinum(II) chloride with DNA: Effects on secondary and tertiary structures of DNA. Cytotoxic assays on human ovarian cancer cell lines, resistant and non-resistant to cisplatin.
    Gay M; Montaña AM; Moreno V; Prieto MJ; Pérez JM; Alonso C
    Bioorg Med Chem; 2006 Mar; 14(5):1565-72. PubMed ID: 16256352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A steroid-binding protein mediates estrogen-dependent inhibition of growth of MCF-7 breast cancer cells.
    Tanji M; Carpenter DO
    Anticancer Res; 2000; 20(4):2785-9. PubMed ID: 10953358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological evaluation of ellipticine-estradiol conjugates.
    Devraj R; Barrett JF; Fernandez JA; Katzenellenbogen JA; Cushman M
    J Med Chem; 1996 Aug; 39(17):3367-74. PubMed ID: 8765520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and characterisation of estrogenic carriers for cytotoxic Pt(II) fragments: biological activity of the resulting complexes.
    Gabano E; Cassino C; Bonetti S; Prandi C; Colangelo D; Ghiglia A; Osella D
    Org Biomol Chem; 2005 Oct; 3(19):3531-9. PubMed ID: 16172691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex hormone-binding globulin antagonizes the anti-apoptotic effect of estradiol in breast cancer cells.
    Catalano MG; Frairia R; Boccuzzi G; Fortunati N
    Mol Cell Endocrinol; 2005 Jan; 230(1-2):31-7. PubMed ID: 15664449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of confocal microscopy to localize the SHBG interaction with human breast cancer cell lines--a comparison with serum albumin interaction.
    Germain P; Egloff M; Kiefer H; Metezeau P; Habrioux G
    Cell Mol Biol (Noisy-le-grand); 1997 Jun; 43(4):501-8. PubMed ID: 9220143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of sex-hormone-binding globulin production by endogenous estrogens in vitro.
    Loukovaara M; Carson M; Adlercreutz H
    Biochem Biophys Res Commun; 1995 Jan; 206(3):895-901. PubMed ID: 7832802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, structure, and estrogenic activity of 4-amino-3-(2-methylbenzyl)coumarins on human breast carcinoma cells.
    Jacquot Y; Laïos I; Cleeren A; Nonclercq D; Bermont L; Refouvelet B; Boubekeur K; Xicluna A; Leclercq G; Laurent G
    Bioorg Med Chem; 2007 Mar; 15(6):2269-82. PubMed ID: 17275315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.